CN112569457B - Continuous administration cyst tube system - Google Patents
Continuous administration cyst tube system Download PDFInfo
- Publication number
- CN112569457B CN112569457B CN202011451940.4A CN202011451940A CN112569457B CN 112569457 B CN112569457 B CN 112569457B CN 202011451940 A CN202011451940 A CN 202011451940A CN 112569457 B CN112569457 B CN 112569457B
- Authority
- CN
- China
- Prior art keywords
- blind end
- sac
- drainage tube
- flow
- shaped blind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
本发明涉及一种持续给药囊管系统,包括囊状盲端、限流通道和引流管,囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;限流通道密封连接在囊状盲端和引流管之间;囊状盲端用于储存流体药物并通过限流通道和引流管向治疗靶点持续灌流流体药物;限流通道用于限定从囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端的持续灌流。
The invention relates to a continuous drug delivery sac system, which includes a sac-shaped blind end, a flow-limiting channel and a drainage tube. The sac-shaped blind end is made of elastic and expandable material and can be buried under the skin; the flow-limiting channel is sealed and connected to the sac-shaped blind end. Between the blind end and the drainage tube; the sac-shaped blind end is used to store fluid drugs and continuously perfuse fluid drugs to the treatment target through the flow-limiting channel and the drainage tube; the flow-limiting channel is used to limit the flow of fluid drugs out of the sac-shaped blind end. The flow rate and flow rate are such that the fluid medicine injected into the sac-shaped blind end is temporarily retained in the sac-shaped blind end, and then the sac-shaped blind end is expanded, thereby maintaining the continuous flow of the fluid medicine from the sac-shaped blind end to the open end of the drainage tube. perfusion.
Description
技术领域Technical field
本发明涉及医疗器械技术领域,具体涉及一种持续给药囊管系统。The invention relates to the technical field of medical devices, and in particular to a continuous drug delivery capsule system.
背景技术Background technique
目前,化疗药的传统给药方式主要为静脉注射,该方法无法精准杀伤肿瘤,因此具有效率低下、副作用大等缺点。局部给药是解决上述问题比较好的改良方案,包括:一次性药物局部注射、多次穿刺局部给药等、经引流管局部注药等。但是,上述局部给药方法都有各自的缺点,限制了其临床应用。At present, the traditional way of administering chemotherapy drugs is mainly intravenous injection. This method cannot accurately kill tumors, so it has shortcomings such as low efficiency and high side effects. Local administration is a better improved solution to solve the above problems, including: one-time local injection of drugs, multiple punctures for local administration, etc., local injection of drugs through drainage tubes, etc. However, the above local administration methods have their own shortcomings, which limit their clinical application.
各种局部给药方法的缺点包括:一次性药物局部注射由于体内空间有限,因此给药总剂量低、作用时间短;多次穿刺局部给药需要CT辅助及较高的技术水平,而且风险较大,很难推广;经引流管局部注药易导致体外细菌通过引流管外口进入体内,有极大的深部感染风险。因此开发新的局部给药装置,以避免上述缺点,具有十分重要的临床意义。The disadvantages of various local drug delivery methods include: due to the limited space in the body, the total dose of one-time local drug injection is low and the action time is short; multiple puncture local drug administration requires CT assistance and a higher technical level, and the risk is relatively high It is large and difficult to promote; local injection through the drainage tube can easily cause bacteria outside the body to enter the body through the outer opening of the drainage tube, posing a great risk of deep infection. Therefore, it is of great clinical significance to develop new local drug delivery devices to avoid the above shortcomings.
发明内容Contents of the invention
本发明旨在提供一种新型的持续给药囊管系统,以解决现有技术中局部给药方案面临的载药量小、作用时间短、穿刺操作风险大、易造成深部感染等问题。The present invention aims to provide a new type of continuous drug delivery capsule system to solve the problems of small drug loading, short action time, high risk of puncture operation, easy to cause deep infection and other problems faced by the local drug delivery scheme in the existing technology.
本发明的目的是解决现有技术的不足,提供一种新型的持续给药囊管系统,包括囊状盲端、限流通道和引流管,所述的囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;所述的限流通道密封连接在囊状盲端和引流管之间;所述的囊状盲端用于储存流体药物并通过限流通道和引流管向治疗靶点持续灌流所述的流体药物;所述的限流通道用于限定从所述的囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端的持续灌流。The purpose of the present invention is to solve the deficiencies of the prior art and provide a new type of continuous drug delivery sac system, which includes a sac-shaped blind end, a flow-limiting channel and a drainage tube. The sac-shaped blind end is made of elastic and expandable material. It is made and can be buried under the skin; the flow-limiting channel is sealed and connected between the sac-like blind end and the drainage tube; the sac-like blind end is used to store fluid medicine and deliver it to the treatment target through the flow-limiting channel and the drainage tube. The fluid medicine is continuously perfused; the flow-limiting channel is used to limit the flow rate and flow rate of the fluid medicine flowing out from the sac-shaped blind end, so that the fluid medicine injected into the sac-shaped blind end is temporarily retained in the sac. into the blind end of the sac, thereby inflating the blind end of the sac to maintain continuous perfusion of fluid medicine from the blind end of the sac to the open end of the drainage tube.
所述的治疗靶点包括人体内肿瘤周围或者是感染病灶周围的位置。The therapeutic targets include locations around tumors or infection lesions in the human body.
所述的引流管的开口端植入在人体深部的治疗靶点。The open end of the drainage tube is implanted into a therapeutic target deep in the human body.
所述的囊状盲端埋藏于皮下以后,允许通过简单的皮下、肌肉或静脉注射技术向埋藏于皮下的囊状盲端注射药物。After the cystic blind end is buried under the skin, drugs can be injected into the cystic blind end buried under the skin through simple subcutaneous, intramuscular or intravenous injection techniques.
优选地,所述的囊状盲端允许采用普通的肌肉注射针头、皮下注射针头或静脉输液针头向埋藏于皮下的囊状盲端注射药物。Preferably, the cystic blind end allows the use of ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles to inject drugs into the cystic blind end buried under the skin.
所述的囊状盲端设置有一个或多个。There are one or more bladder-shaped blind ends.
所述的开口端设置有一个或多个。There are one or more said open ends.
所述的囊状盲端、限流通道和引流管采用弹性硅胶做成。The sac-shaped blind end, flow-limiting channel and drainage tube are made of elastic silicone.
所述的囊状盲端能够储药10ml至400ml。The cystic blind end can store 10ml to 400ml of medicine.
所述的限流通道使得从所述的囊状盲端流出的流体药物的限制流速为0.5ml/天至10ml/天,平均给药周期为1周至1年。The flow-limiting channel allows the restricted flow rate of the fluid medicine flowing out from the sac-shaped blind end to be 0.5 ml/day to 10 ml/day, and the average administration period is 1 week to 1 year.
有益效果beneficial effects
与现有技术相比,本发明的有益效果是:Compared with the prior art, the beneficial effects of the present invention are:
本发明所述的持续给药囊管系统通过将传统硅胶引流管的一端做成膨大的囊状盲端,用于埋植于皮下,以储存药物并接受体外注药,应用过程中,埋藏于皮下的囊状盲端可以容纳较多药物,从而解决一次性药物局部注射所面临的载药量小的问题;由于本发明所述的持续给药囊管系统可用于反复多次给药,并且限流通道可以维持药物的持续灌流,避免了一次性药物局部注射所面临的作用时间短的问题;在使用本发明所述的持续给药囊管系统时,用于局部给药的穿刺操作与常规的皮下、肌肉或静脉注射操作类似,无需CT辅助,避免了多次穿刺局部给药所面临的穿刺操作难度高、风险大的问题;本发明所述的持续给药囊管系统的囊状盲端埋藏于皮下,无体外部分,减少了体外细菌通过引流管外口进入体内造成深部感染的风险。The continuous drug administration capsule system of the present invention makes one end of the traditional silicone drainage tube into an enlarged capsule-shaped blind end, which is used to be buried under the skin to store drugs and receive in vitro injection. During the application process, it is buried in the The subcutaneous blind end of the capsule can accommodate more drugs, thereby solving the problem of small drug loading faced by one-time local injection of drugs; because the continuous drug delivery capsule system of the present invention can be used for repeated administration, and The flow-limiting channel can maintain continuous perfusion of drugs and avoid the problem of short action time faced by local injection of one-time drugs; when using the continuous drug delivery capsule system of the present invention, the puncture operation for local drug administration and Conventional subcutaneous, intramuscular or intravenous injection operations are similar and do not require CT assistance, thus avoiding the problems of high difficulty and high risk of puncture operations faced by multiple punctures for local administration; the capsule-shaped continuous drug delivery sac system of the present invention The blind end is buried under the skin and has no external part, which reduces the risk of external bacteria entering the body through the external opening of the drainage tube and causing deep infection.
附图说明Description of the drawings
附图用来提供对本发明技术方案的进一步理解,并且构成说明书的一部分,与本申请的具体实施方式一起用于解释本发明的技术方案,并不构成对本发明技术方案的限制。The drawings are used to provide a further understanding of the technical solution of the present invention, and constitute a part of the description. They are used to explain the technical solution of the present invention together with the specific embodiments of the present application, and do not constitute a limitation of the technical solution of the present invention.
图1是本发明所述的持续给药囊管系统的整体结构示意图。Figure 1 is a schematic diagram of the overall structure of the continuous drug delivery capsule system of the present invention.
具体实施方式Detailed ways
在下文中更详细地描述了本发明以有助于对本发明的理解。The invention is described in more detail below to facilitate understanding of the invention.
如图1所示,本发明所述的持续给药囊管系统包括囊状盲端1、限流通道2和引流管3,所述的囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;所述的限流通道2密封连接在囊状盲端1和引流管3之间;所述的囊状盲端用于储存流体药物并通过限流通道2和引流管3向治疗靶点持续灌流所述的流体药物;所述的限流通道2用于限定从所述的囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端4的持续灌流。As shown in Figure 1, the continuous drug delivery bladder system of the present invention includes a bladder-shaped blind end 1, a flow-limiting channel 2 and a drainage tube 3. The bladder-shaped blind end is made of elastic and expandable material and can be buried. subcutaneously; the flow-limiting channel 2 is sealingly connected between the sac-like blind end 1 and the drainage tube 3; the sac-like blind end is used to store fluid medicine and deliver it to the treatment target through the flow-restricting channel 2 and the drainage tube 3 The fluid medicine is continuously perfused at one point; the flow-limiting channel 2 is used to limit the flow rate and flow rate of the fluid medicine flowing out from the sac-shaped blind end, so that the fluid medicine injected into the sac-shaped blind end temporarily remains. In the sac-like blind end, the sac-like blind end is then expanded to maintain continuous perfusion of fluid medicine from the sac-shaped blind end to the open end 4 of the drainage tube.
所述的治疗靶点包括人体内肿瘤周围或者是感染病灶周围的位置。The therapeutic targets include locations around tumors or infection lesions in the human body.
所述的引流管的开口端植入在人体深部的治疗靶点。The open end of the drainage tube is implanted into a therapeutic target deep in the human body.
所述的囊状盲端埋藏于皮下以后,允许通过简单的皮下、肌肉或静脉注射技术向埋藏于皮下的囊状盲端注射药物。After the cystic blind end is buried under the skin, drugs can be injected into the cystic blind end buried under the skin through simple subcutaneous, intramuscular or intravenous injection techniques.
优选地,所述的囊状盲端允许采用普通的肌肉注射针头、皮下注射针头或静脉输液针头向埋藏于皮下的囊状盲端注射药物。Preferably, the cystic blind end allows the use of ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles to inject drugs into the cystic blind end buried under the skin.
进一步优选地,所述的囊状盲端设置有一个或多个,所述的开口端也设置有一个或多个,以实现一种或多种药物的载药和递送。It is further preferred that one or more sac-like blind ends are provided, and one or more open ends are also provided, to achieve drug loading and delivery of one or more drugs.
所述的囊状盲端、限流通道和引流管采用弹性硅胶做成。The sac-shaped blind end, flow-limiting channel and drainage tube are made of elastic silicone.
本发明所述的持续给药囊管系统是在传统硅胶引流管的基础上改进而来,只保留传统引流管的体内部分,并且将引流管浅部一端用弹性硅胶做成可膨胀的囊状盲端,囊状盲端与引流管之间留有一狭窄的限流通道,该限流通道仅能让液体缓慢流过(囊状盲端储药约10-400ml,限流通道使得限制流速0.5-10ml/天,平均给药周期约1周-1年),以使注入膨胀盲端的药物暂时留存,继而使囊状盲端膨胀,从而维持药物从盲端向开口端的持续灌流。使用者可按照传统引流管的植入方式,将本发明的开口端植入深部的治疗靶点(如肿瘤周围或者是感染病灶周围),然后将本发明的囊状盲端埋藏于皮下。术后,只需利用普通的肌肉注射针头、皮下注射针头或静脉输液针头,采用简单的皮下、肌肉或静脉注射技术,即可向埋藏于皮下的囊状盲端注射药物;注入囊状盲端的药物可经过引流管进入深部的治疗靶点,达到精准治疗的效果。The continuous drug delivery capsule system of the present invention is improved on the basis of traditional silicone drainage tubes. Only the internal body part of the traditional drainage tube is retained, and the shallow end of the drainage tube is made into an expandable bladder shape with elastic silicone. Blind end, there is a narrow flow-limiting channel between the sac-like blind end and the drainage tube, which can only allow liquid to flow slowly (the sac-like blind end stores about 10-400ml of medicine, and the flow-limiting channel limits the flow rate to 0.5 -10ml/day, the average administration period is about 1 week to 1 year), so that the drug injected into the expanded blind end is temporarily retained, and then the cystic blind end is expanded to maintain continuous perfusion of the drug from the blind end to the open end. The user can implant the open end of the present invention into a deep treatment target (such as around a tumor or an infected lesion) according to the traditional drainage tube implantation method, and then bury the cystic blind end of the present invention under the skin. After surgery, you only need to use ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles, and use simple subcutaneous, intramuscular or intravenous injection techniques to inject drugs into the cystic blind end buried under the skin; inject drugs into the cystic blind end. Drugs can enter deep treatment targets through the drainage tube to achieve precise treatment effects.
本发明中所述囊状盲端、限流通道和引流管的材料不限于硅胶材料,其他可用于人体植入的材料均可作为硅胶的替代材料。The materials of the sac-shaped blind end, the flow-limiting channel and the drainage tube in the present invention are not limited to silicone materials, and other materials that can be used for human body implantation can be used as substitute materials for silicone.
以上描述了本发明优选实施方式,然其并非用以限定本发明。本领域技术人员对在此公开的实施方案可进行并不偏离本发明范畴和精神的改进和变化。The preferred embodiments of the present invention have been described above, but they are not intended to limit the present invention. Those skilled in the art may make modifications and changes to the embodiments disclosed herein without departing from the scope and spirit of the invention.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011451940.4A CN112569457B (en) | 2020-12-10 | 2020-12-10 | Continuous administration cyst tube system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011451940.4A CN112569457B (en) | 2020-12-10 | 2020-12-10 | Continuous administration cyst tube system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112569457A CN112569457A (en) | 2021-03-30 |
| CN112569457B true CN112569457B (en) | 2024-02-13 |
Family
ID=75131229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011451940.4A Active CN112569457B (en) | 2020-12-10 | 2020-12-10 | Continuous administration cyst tube system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112569457B (en) |
Citations (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1130743A (en) * | 1956-08-30 | 1957-02-11 | Flexible containers | |
| US3796217A (en) * | 1972-03-10 | 1974-03-12 | Hydr Med Sciences Inc | Drug release system |
| US5688237A (en) * | 1995-05-04 | 1997-11-18 | Cedars-Sinai Medical Center | Implantable catheter and method of use |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| CN2362514Y (en) * | 1998-11-03 | 2000-02-09 | 陈军 | Embedding type medicine introducing device |
| US20030014036A1 (en) * | 2001-06-12 | 2003-01-16 | Varner Signe Erickson | Reservoir device for intraocular drug delivery |
| US20030078550A1 (en) * | 2001-10-22 | 2003-04-24 | Williamson Shobha Devi | Implantable pump catheter access port denial device |
| US20030171401A1 (en) * | 1999-03-18 | 2003-09-11 | Johnson Randolph Mellus | Devices and methods for pain management |
| CN2712349Y (en) * | 2004-07-12 | 2005-07-27 | 郑士全 | Subcutaneous implantable sustained-release silica gel rod for antipsychotics |
| CN1787844A (en) * | 2003-05-29 | 2006-06-14 | 瑞尼斯豪公司 | Implantable pump |
| CN200998518Y (en) * | 2006-11-03 | 2008-01-02 | 刘爱军 | Micro-wound implanting type radiotherapy bursa |
| CN101224315A (en) * | 2007-12-28 | 2008-07-23 | 李楠 | Infusion method of multiple medicine and velocity and device thereof |
| WO2009125181A1 (en) * | 2008-04-08 | 2009-10-15 | Epsom And St Helier University Hospitals Nhs Trust | Subcutaneous port and catheter |
| US20110208122A1 (en) * | 2010-02-22 | 2011-08-25 | Avraham Shekalim | Slow release liquid drug delivery device |
| CN104857622A (en) * | 2015-06-10 | 2015-08-26 | 徐增良 | Drainage tube |
| CN106470731A (en) * | 2014-03-27 | 2017-03-01 | 贝塔O2技术有限公司 | Implantable medical device |
| US20170095653A1 (en) * | 2015-10-06 | 2017-04-06 | The Johns Hopkins University | Universal microport |
| CN107735142A (en) * | 2015-04-07 | 2018-02-23 | 伊哈卜·萨阿卜 | Implantable Fluid Delivery Systems |
| CN107753418A (en) * | 2017-11-20 | 2018-03-06 | 中国农业科学院北京畜牧兽医研究所 | Medicament slow release implants and heeling-in device |
| CN108042899A (en) * | 2018-01-24 | 2018-05-18 | 山东百多安医疗器械有限公司 | A kind of dual valve implantable drug delivery system |
| CN110841134A (en) * | 2018-08-20 | 2020-02-28 | 张海军 | Automatic drug delivery system for treating Parkinson's disease |
| KR20200032023A (en) * | 2019-12-06 | 2020-03-25 | 주식회사 유니메딕스 | Patient controlled drug administration device |
| CN214633242U (en) * | 2020-12-10 | 2021-11-09 | 北京大学第三医院(北京大学第三临床医学院) | Fully-implanted deep continuous administration silicone capsule tube system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003208901A1 (en) * | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Microinfusion device |
| US10307581B2 (en) * | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
| US20090149838A1 (en) * | 2007-12-10 | 2009-06-11 | Cassada David C | Subcutaneous Implant System |
-
2020
- 2020-12-10 CN CN202011451940.4A patent/CN112569457B/en active Active
Patent Citations (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1130743A (en) * | 1956-08-30 | 1957-02-11 | Flexible containers | |
| US3796217A (en) * | 1972-03-10 | 1974-03-12 | Hydr Med Sciences Inc | Drug release system |
| US5688237A (en) * | 1995-05-04 | 1997-11-18 | Cedars-Sinai Medical Center | Implantable catheter and method of use |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| CN2362514Y (en) * | 1998-11-03 | 2000-02-09 | 陈军 | Embedding type medicine introducing device |
| US20030171401A1 (en) * | 1999-03-18 | 2003-09-11 | Johnson Randolph Mellus | Devices and methods for pain management |
| US20030014036A1 (en) * | 2001-06-12 | 2003-01-16 | Varner Signe Erickson | Reservoir device for intraocular drug delivery |
| US20030078550A1 (en) * | 2001-10-22 | 2003-04-24 | Williamson Shobha Devi | Implantable pump catheter access port denial device |
| CN1787844A (en) * | 2003-05-29 | 2006-06-14 | 瑞尼斯豪公司 | Implantable pump |
| CN2712349Y (en) * | 2004-07-12 | 2005-07-27 | 郑士全 | Subcutaneous implantable sustained-release silica gel rod for antipsychotics |
| CN200998518Y (en) * | 2006-11-03 | 2008-01-02 | 刘爱军 | Micro-wound implanting type radiotherapy bursa |
| CN101224315A (en) * | 2007-12-28 | 2008-07-23 | 李楠 | Infusion method of multiple medicine and velocity and device thereof |
| WO2009125181A1 (en) * | 2008-04-08 | 2009-10-15 | Epsom And St Helier University Hospitals Nhs Trust | Subcutaneous port and catheter |
| US20110208122A1 (en) * | 2010-02-22 | 2011-08-25 | Avraham Shekalim | Slow release liquid drug delivery device |
| CN106470731A (en) * | 2014-03-27 | 2017-03-01 | 贝塔O2技术有限公司 | Implantable medical device |
| CN107735142A (en) * | 2015-04-07 | 2018-02-23 | 伊哈卜·萨阿卜 | Implantable Fluid Delivery Systems |
| CN104857622A (en) * | 2015-06-10 | 2015-08-26 | 徐增良 | Drainage tube |
| US20170095653A1 (en) * | 2015-10-06 | 2017-04-06 | The Johns Hopkins University | Universal microport |
| CN107753418A (en) * | 2017-11-20 | 2018-03-06 | 中国农业科学院北京畜牧兽医研究所 | Medicament slow release implants and heeling-in device |
| CN108042899A (en) * | 2018-01-24 | 2018-05-18 | 山东百多安医疗器械有限公司 | A kind of dual valve implantable drug delivery system |
| CN110841134A (en) * | 2018-08-20 | 2020-02-28 | 张海军 | Automatic drug delivery system for treating Parkinson's disease |
| KR20200032023A (en) * | 2019-12-06 | 2020-03-25 | 주식회사 유니메딕스 | Patient controlled drug administration device |
| CN214633242U (en) * | 2020-12-10 | 2021-11-09 | 北京大学第三医院(北京大学第三临床医学院) | Fully-implanted deep continuous administration silicone capsule tube system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112569457A (en) | 2021-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017202439B2 (en) | Implantable solid-liquid drug delivery apparatus, formulations, and methods of use | |
| AU742061B2 (en) | Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation | |
| CN206007700U (en) | A kind of full-implantation type venous transfusion port | |
| CN112569457B (en) | Continuous administration cyst tube system | |
| CN214633242U (en) | Fully-implanted deep continuous administration silicone capsule tube system | |
| CN102151346A (en) | Hypodermic implantation type medicine feeder | |
| CN206621657U (en) | A kind of elastic micropin containing solvable syringe needle | |
| CN209270606U (en) | Orthopedic implantable drug delivery device | |
| CN215426894U (en) | Bladder cancer postoperative perfusion device | |
| CN215780558U (en) | Improved disposable continuous infusion pump suitable for transarterial administration | |
| CN209630432U (en) | A subcutaneous implantable drug delivery device | |
| CN211188555U (en) | Subcutaneous implantation type abdominal cavity chemotherapy device | |
| CN202061177U (en) | Hypodermic implantation type drug administration device | |
| CN208942082U (en) | Drug delivery device under a kind of simple hysteroscope | |
| US20070073239A1 (en) | Catheter device | |
| CN208974039U (en) | Bone joint infection drug delivery device | |
| CN100387315C (en) | Minimally invasive treatment tube for mammary abscess | |
| WO2006108336A1 (en) | Implantable administrating catheter | |
| CN222752413U (en) | Subcutaneous implantation type bladder drug delivery device | |
| CN2098297U (en) | Multifunctional medical capsule catheter | |
| CN208785472U (en) | A kind of Internal Medicine-Oncology drug delivery device | |
| CN214911512U (en) | Disposable low-pressure enemator | |
| CN223208815U (en) | Radiopharmaceutical injection device | |
| CN214550516U (en) | An implantable intraperitoneal subcutaneous chemotherapy device | |
| CN204910431U (en) | Heart in situ perfusion pipe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |